2005
DOI: 10.1007/s00125-005-0031-4
|View full text |Cite
|
Sign up to set email alerts
|

Essential role of the imidazoline moiety in the insulinotropic effect but not the KATP channel-blocking effect of imidazolines; a comparison of the effects of efaroxan and its imidazole analogue, KU14R

Abstract: Essential role of the imidazoline moiety in the insulinotropic effect but not the K ATP channel-blocking effect of imidazolines; a comparison of the effects of efaroxan and its imidazole analogue, KU14R Abstract Aims/hypothesis: Imidazolines are a class of investigational antidiabetic drugs. It is still unclear whether the imidazoline ring is decisive for insulinotropic characteristics. Materials and methods: We studied the imidazoline efaroxan and its imidazole analogue, KU14R, which is currently classified a… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
20
0

Year Published

2006
2006
2017
2017

Publication Types

Select...
7

Relationship

2
5

Authors

Journals

citations
Cited by 18 publications
(22 citation statements)
references
References 41 publications
2
20
0
Order By: Relevance
“…These compounds were used at a concentration which inhibits B-cell KATP channel activity by about 85% [29], which is comparable to the effect of 100 µM gatifloxacin on reconstituted KATP channels [11]. While tolbutamide closes these channels by binding to the regulatory subunit, SUR1 [12], efaroxan, like the fluoroquinolones, inhibits KATP channels by binding to the pore-forming unit, Kir 6.2 [29].…”
Section: Page 11 Of 30mentioning
confidence: 99%
See 1 more Smart Citation
“…These compounds were used at a concentration which inhibits B-cell KATP channel activity by about 85% [29], which is comparable to the effect of 100 µM gatifloxacin on reconstituted KATP channels [11]. While tolbutamide closes these channels by binding to the regulatory subunit, SUR1 [12], efaroxan, like the fluoroquinolones, inhibits KATP channels by binding to the pore-forming unit, Kir 6.2 [29].…”
Section: Page 11 Of 30mentioning
confidence: 99%
“…While tolbutamide closes these channels by binding to the regulatory subunit, SUR1 [12], efaroxan, like the fluoroquinolones, inhibits KATP channels by binding to the pore-forming unit, Kir 6.2 [29].…”
Section: Page 11 Of 30mentioning
confidence: 99%
“…Islets were dissociated into single cells by incubation for 10 min in a Ca 2+ -free medium (135 mmol/l NaCl, 4.8 mmol/l KCl, 1.2 mmol/l KH 2 PO 4 , 1.2 mmol/l MgSO 4 , 25 mmol/l HEPES, 0.5 mmol/l EGTA, 3 mmol/l glucose, 1% BSA, pH 7.4), subsequent vortexmixing for 1 min, centrifugation for 1 min at 200 g and suspension in culture medium. Isolated islets were cultured in the presence of 5 mmol/l glucose (for microfluorimetric measurements) and islet cells in the presence of 10 mmol/l glucose (for patch-clamp experiments) as described previously [23,24].…”
Section: Materials and Mediamentioning
confidence: 99%
“…The loading concentration was 2 μmol/l in basal medium containing 2 mg/ml BSA and 5 mmol/l glucose (45 min at 37°C). As described previously [24], the islets were then perifused at 0.2 ml/min and at 35°C using basal medium (additions as detailed under Results, no BSA) and the epifluorescence was recorded (six islet subregions evaluated per experiment).…”
Section: +mentioning
confidence: 99%
“…Thus, the earlier hypothesis that the characteristics of the imidazoline effect are due to a sensitization of the exocytotic machinery to [Ca 2ϩ ] c (Zaitsev et al, 1996) (Liu et al, 1998). Most likely, the [Ca 2ϩ ] c oscillation is the direct consequence of the oscillatory ␤-cell membrane depolarization elicited by efaroxan in the presence of 5 mM glucose (Bleck et al, 2005). The repolarization despite the continuous presence of efaroxan may result from the marked susceptibility of the K ATP channel block by efaroxan to the opening effect of nucleoside diphosphates (Wienbergen et al, 2007).…”
Section: Insulinotropic Effect Of Imidazolinesmentioning
confidence: 98%